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Abstract
Background: Obstructive jaundice has been reported to influence liver elasticity, independent of liver fibrosis. The
aim of our prospective study was to evaluate the changes in liver elasticity, before and after biliary drainage, in
patients with obstructive jaundice, and to evaluate the correlation between elasticity measures and serum markers
of liver fibrosis.
Methods: This is a prospective cohort study of 20 patients with obstructive jaundice. Liver elasticity was assessed
by Transient Elastography (TE) and Virtual Touch™ Quantification (VTQ). Serum total bilirubin (T-Bil) level was
measured before biliary drainage (Day 0), with measures repeated at 2 days (Day 2) and 7 days (Day 7) after biliary
drainage. Serum levels of the following markers of liver fibrosis were also obtained on Day 0 and Day 7: hyaluronic
acid (HA), procollagen-III-peptide (P-III-P).
Results: T-Bil, TE, and VTQ for the left (VTQ-L) and right (VTQ-R) lobes of the liver were all elevated before biliary
drainage, with respective levels, measured at Day 0, of 11.9 ± 1.5 mg/dl, 12.1 ± 0.9 kPa, 2.23 ± 0.10 m/s, and 1.85 ± 0.
10 m/s. All values decreased on Day 7 after drainage: T-Bil, 4.7 ± 1.0 mg/dl (P < 0.001); TE, 7.6 ± 0.6 kPa (P < 0.001);
VTQ-L, 1.53 ± 0.08 m/s (P < 0.001); and VTQ-R, 1.30 ± 0.05 m/s (P < 0.001). Similar changes were observed in serum
markers of liver fibrosis. Liver elasticity measures correlated with serum levels of T-Bil, P-III-P, and HA (r = 0.35-0.67,
P < 0.001).
Conclusions: This study confirmed decreases in liver elasticity, measured by TE and VTQ, after biliary drainage.
Measures of liver elasticity correlated to levels of T-Bil and serum markers of liver fibrosis. (UMIN ID:
UMIN00001284313).
Trial registration: Registration number: University Hospital Medical Information Network (UMIN) Clinical Trials
Registry (UMIN ID: UMIN00001284313); Registration date: 2014-01-14.
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Background
The grade of liver fibrosis is a major indicator of the
progression of chronic liver disease. Liver biopsy is con-
sidered to be an essential method [1] for conducting
pathological evaluation of the fibrotic tissues. However,
liver biopsy is associated with various complications,
some of which can be life-threatening [2, 3]. As alterna-
tives to liver biopsy, several non-invasive serum
markers, such as hyaluronic acid (HA), procollagen-III-
peptide (P-III-P), type IV collagen 7S (IV collagen), and
two associated liver fibrosis scores, Forns’ Index and
the Fibro Index, have been used to assess liver fibrosis
[4–6]. Recently, several ultrasound-based methods have
been developed to quantify liver elasticity for the as-
sessment of liver fibrosis. The best known methods
among these are Transient Elastography (TE) and
Virtual Touch™ Quantification (VTQ) [7]. TE measures
the propagation velocity of a single-cycle shear wave
generated by a probe [8], with values expressed in units
of pressure (kilopascal, kPa). In contrast, VTQ mea-
sures the propagation velocity of a transverse shear
wave generated by a short-duration acoustic push pulse
[9], with values expressed in units of velocity (meter
per second, m/s). Compared to TE, VTQ offers the ad-
vantage of real-time elastography being integrated into
a conventional ultrasound system. Furthermore, VTQ
can be used to evaluate liver tissue over a wide range of
depths and, therefore, provides a feasible method for
the examination of patients with ascites for whom TE
cannot be applied. Meta-analyses have provided evi-
dence supporting both TE and VTQ as non-invasive
methods for evaluating the stage of liver fibrosis, each
providing high diagnostic accuracy to differentiate liver
fibrosis and liver cirrhosis [10–12].
Obstructive jaundice has been known to be caused
mainly by pancreaticobiliary diseases. Several studies
have reported that biliary obstruction causes cholestatic
injury to the liver, including hepatocellular necrosis and
apoptosis, bile duct epithelial cell proliferation, and
liver fibrosis [13–15]. As well, obstructive jaundice has
been reported to be closely associated with changes in
liver elasticity, independent of liver fibrosis [16–21].
However, the effects of obstructive jaundice on liver
elasticity and the correlation of liver elasticity and non-
invasive serum markers of liver fibrosis, such as HA
and P-III-P, have not been examined and remain to be
fully characterized.
The aim of our prospective study was to evaluate
the changes in liver elasticity, measured before and
after biliary drainage, in patients with obstructive
jaundice using TE and VTQ, and to evaluate the cor-
relation between liver elasticity measures, obtained




Participants for our prospective cohort study were pa-
tients with obstructive jaundice, admitted to Hokkaido
University Hospital from July 2013 to January 2015. Pro-
spective participants were screened on the following
inclusion criteria: confirmed diagnosis of obstructive
jaundice based on imaging examination; total serum bili-
rubin (T-Bil) level > 2 mg/dl, and clinical indication for
biliary drainage. Patients with chronic liver disease, liver
tumors, ascites, acute cholangitis, or contraindications
to biliary drainage, were excluded. Written informed
consent was obtained from all patients. This study was ap-
proved by our institutional review board (No. 013–0174)
and was registered in the University Hospital Medical
Information Network (UMIN) Clinical Trials Registry
(UMIN ID: UMIN00001284313).
Measurements of liver elasticity
A single experienced operator (K.K.) measured liver elas-
ticity by TE, using a Fibroscan® (Echosens, Paris, France),
and by VTQ, using ACUSON S2000® (Mochida SIE-
MENS Medical Systems, Tokyo, Japan). TE and VTQ
measurements were completed at the same session for
all patients. Values measured by TE were expressed in
kPa, with a mean (range) value of 5.5 (1.5–12.7) kPA
considered to be normal [22]. Values measured by VTQ
were expressed in m/s, with a mean (range) value of
1.59 (0.76–3.43) m/s considered to be normal [23].
TE was measured for the right lobe of the liver, with
access through the overlying intercostal space; and ob-
tained under a condition of fasting. VTQ was measured
at two sites, the right lobe of the liver (VTQ-R), accessed
through the overlying intercostal space, and the left lobe
of the liver (VTQ-L) which was also accessed through
the overlying intercostal space but at a depth of 2–4 cm.
Liver elasticity was measured in all patients before bil-
iary drainage (Day 0), and at 2 days (Day 2) and 7 days
(Day 7) post-biliary drainage. If possible, a fourth liver
elasticity measurement was obtained during the follow-up
period at the time when T-Bil level dropped to < 2 mg/dl
(Fig. 1).
The results were considered to be reliable when a suc-
cess rate of measurement of at least 60 % in 10 acquisition
trials (i.e., ratio between validated and total measure-
ments) was obtained. In addition, the median value was
considered to be representative of TE and VTQ measure-
ment only if the interquartile range (IQR) of all validated
measurements was within 30 % of the median value.
Serum markers of liver fibrosis and total bilirubin
Blood samples were obtained from all patients on the
day when measurements of liver elasticity were per-
formed. Levels of the following serum markers of liver
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fibrosis were examined: T-Bil level, HA, P-III-P, and IV col-
lagen. T-Bil was examined at all time-points of measure-
ment, while HA, P-III-P and IV collagen were examined at
Days 0 and 7. The following serum liver fibrosis scores
were calculated using previously published formulas:
Forns’ Index6 ¼ 7:811−3:131: ln ðplatelet 109=L½ Þ
þ 0:781: ln ðγ‐GT IU=LÞ
þ 3:467: ln ageð Þ ‐ 0:014 cholesterol mg=dL½ ð Þ
ð1Þ
Fibro Index4 ¼ 1:738‐0:064 platelet 104=mm3½ ð Þ
þ 0:005 AST IU=L½ ð Þ
þ 0:463 γ‐globulin g=dl½ ð Þ
ð2Þ
Aspartate Aminotransferase‐to‐platelet Ratio Index APRIð Þ5
¼ AST IU=L½  =ULNð Þ  100=platelet 109=L½ :
ð3Þ
Biliary drainage
All patients underwent biliary drainage by endoscopic
biliary stenting (EBS), endoscopic nasobiliary drainage
(ENBD), or endoscopic ultrasonography-guided choledo-
choduodenostomy (EUS-CDS). Biliary drainage proce-
dures were performed under conscious sedation, using
fentanyl and midazolam by single experienced operator
(H.K.). EBS and ENBD were performed using a duodenal
endoscope (TJF-260 V, Olympus, Tokyo, Japan), a 0.025-
inch guidewire (VisiGlide™, Olympus), and either a 7-Fr
tube stent (Flexima, Boston Scientific Japan, Tokyo,
Japan) or a 5-Fr or 6-Fr nasobiliary drainage tube (Sumi-
tomo Bakelite, Tokyo, Japan or Olympus). EUS-CDS was
performed using an echoendoscope (GF-UCT240-AL5,
Olympus), a 19-gauge needle (Cook Japan, Tokyo, Japan),
a guidewire, a 6Fr diathermic dilator (Cysto-Gastro-Set,
Endo-flex, Voerde, Germany), and a partially covered
self-expandable metallic stent (WallFlex™; 10 × 60 mm,
Boston Scientific Japan).
Sample size
In this study, we assessed whether liver elasticity was de-
creased after biliary drainage in patients with obstructive
jaundice. Based on previously published clinical data
[18], a 3.8 kPa change in TE values, before and after bil-
iary drainage, was assumed. As no standard deviation
data on TE measures of liver elasticity, measured pre-
and post-biliary drainage, have been published, we as-
sumed a moderate correlation (r = 0.5) between our
scores and the mean change of 3.8 kPA. Based on this
assumption, a sample size of 14 patients would provide
91 % power to detect a decrease in liver elasticity after
biliary drainage, using a paired Student’s t-test, with a
significance level of 0.05 (two-sided). Assuming there
would be some dropouts of enrolled patients, our re-
cruitment goal was set at 20 patients.
Statistical analysis
Data were analyzed using JMP, version 10.0.2 (SAS Insti-
tute, Cary, NC, USA). Data were expressed as mean ± SE.
Continuous variables were compared using paired Student’s
t-tests. Correlations between parameters were determined
by Pearson’s product–moment correlation coefficient. Dif-
ferences were considered significant at P < 0.05.
Results
Patient characteristics
Twenty-two patients with obstructive jaundice associ-
ated to malignant tumors and meeting the clinical cri-
teria for biliary drainage were enrolled into the study. Of
these, 20 patients underwent liver elasticity measure-
ment before and after biliary drainage, with the success
rate of measurement and the median value of IQR all
considered to be reliable by the validation criteria de-
scribed in the previous section. For the other 2 patients,
liver elasticity could not be accurately evaluated after
biliary drainage due to post-ERCP pancreatitis and early
stent obstruction. The data from these two patients was
excluded from the analysis. Of these 20 patients, 4 pa-
tients were loss to follow-up, 3 patients were transferred
to other hospitals, and 3 patients underwent surgery.
Therefore, 10 patients underwent liver elasticity meas-
urement in the follow-up period.
The relevant characteristics of the patients forming our
study group are presented in Table 1 and summarized as
Hospital inpatients with obstructive jaundice
(July.2013-January.2015)
N=22
Ultrasonography with Fibroscan and ARFI before drainage
N=22
Ultrasonography with Fibroscan and ARFI after drainage
N=20
Ultrasonography with Fibroscan and ARFI at follow up
N=10
Exclusion
Post-ERCP pancreatitis 1 
Stent obstruction 1
Loss to follow up 4 
Changing hospital 3
Surgery 3
Fig. 1 Flow chart of participant recruitment
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follows: 12 males, mean age of 69.9 years, and mean
body mass index of 22.0 kg/m2. All patients had car-
cinoma, originating from different primary sites: the
pancreas in 10 patients, the bile duct in 7, the am-
pulla of Vater in 2, and the gallbladder in 1. The site of
biliary obstruction was hilar in 7 patients and distal
obstruction in 13 patients. Biliary drainage was per-
formed by EBS in 7 patients, ENBD in 6 and EUS-CDS
in 7. The mean duration of follow-up was 38.9 days
(range, 8 to136 days).
Changes in T-Bil levels and liver elasticity
T-Bil, TE, VTQ-L, and VTQ-R values were all elevated
before biliary drainage, with values of: T-Bil, 11.9 ±
1.5 mg/dl, TE, 12.1 ± 0.9 kPa; VTQ-L, 2.23 ± 0.10 m/s;
and VTQ-R 1.85 ± 0.10 m/s. All values decreased signifi-
cantly at post-drainage Day 7, respectively, to values of:
4.7 ± 1.0 mg/dl (P < 0.001), 7.6 ± 0.6 kPa (P < 0.001),
1.53 ± 0.08 m/s (P < 0.001), and 1.30 ± 0.05 m/s (P < 0.001)
(Table 2 and Fig. 2a). The rate of change in values was
higher from Day 0 to Day 2, compared to the rate of
change from Day 2 to Day 7 (Fig. 2b). For 10 patients,
further measurements of liver elasticity were obtained
during the follow-up period, with values further decreas-
ing: TE, 6.7 ± 0.9 kPa; VTQ-L, 1.28 ± 0.07 m/s; and VTQ-R,
1.16 ± 0.08 m/s (Fig. 2c). In addition, the VTQ-L value was
significantly higher than the VTQ-R value at each
time-point of measurement (Fig. 2b).
Changes of serum markers of liver fibrosis
Values for serum markers and liver fibrosis scores
were elevated in all patients before drainage: HA,
324.2 ± 61.4 ng/ml; P-III-P, 1.40 ± 0.10 U/ml; IV colla-
gen, 7.9 ± 0.9 ng/ml; Forns’ Index, 6.98 ± 0.41; Fibro
Index, 1.69 ± 0.18; and APRI, 2.60 ± 0.40. After biliary
drainage, all values decreased at Day 7: HA, 199.9 ±
41.6 ng/ml (P = 0.002); P-III-P, 1.14 ± 0.07 U/ml (P =
0.004); IV collagen, 7.2 ± 0.6 ng/ml (P =NS); Forn's index,
6.76 ± 0.42 (P =NS); Fibro Index, 0.73 ± 0.13 (P < 0.001);
and APRI, 0.79 ± 0.15 (P < 0.001) (Table 2 and Fig. 3a-f).
Table 1 Patient characteristics
Male/Female 12/8
Age (mean, range) 69.9 (59–88)










Observation period (mean, range) 38.9 (8–136)
EUS-CDS Endoscopic ultrasound (EUS)-guided choledochoduodenostomy, EBS
Endoscopic biliary stenting, ENBD Endoscopic nasobiliary drainage
Table 2 Liver elasticity, serum data, and serum markers, measured before and after biliary drainage
Day 0 (n = 20) Day 2 (n = 20) Day 7 (n = 20) > Day 7 (n = 10) P*
TE (kPa) 12.1 ± 0.9 9.2 ± 0.8 7.6 ± 0.6 6.7 ± 0.9 <0.001
VTQ-L (m/s) 2.23 ± 0.10 1.76 ± 0.09 1.53 ± 0.08 1.28 ± 0.07 <0.001
VTQ-R (m/s) 1.85 ± 0.10 1.50 ± 0.05 1.30 ± 0.05 1.16 ± 0.08 <0.001
T-Bil (mg/dl) 11.9 ± 1.5 8.0 ± 1.4 4.7 ± 1.0 1.0 ± 0.1 <0.001
AST (U/L) 209.8 ± 28.8 129.4 ± 23.0 66.8 ± 7.7 34.3 ± 6.6 <0.001
γ-GT (U/L) 1123.7 ± 166.2 839.0 ± 123.2 416.6 ± 63.7 202.4 ± 51.1 <0.001
ALP (U/L) 2,325.1 ± 217 1,987.9 ± 198.2 1,258.2 ± 126.5 682.8 ± 164.1 <0.001
Plt (×104/μl) 25.9 ± 1.3 26.3 ± 1.5 29.2 ± 1.7 24.2 ± 1.7 NS
γ-globulin (g/dl) 1.20 ± 0.05 1.14 ± 0.06 1.09 ± 0.09 0.011
T-cho (mg/dl) 243.7 ± 17.5 186.5 ± 13.8 172.9 ± 12.4 <0.001
Hyaluronic acid (ng/ml) 324.2 ± 61.4 199.9 ± 41.6 118.0 ± 25.7 0.002
P-III-P (U/ml) 1.40 ± 0.10 1.14 ± 0.07 0.09 ± 0.08 0.004
IV collagen (ng/ml) 7.9 ± 0.9 7.2 ± 0.6 6.5 ± 0.8 NS
Forns' Index 6.98 ± 0.41 6.76 ± 0.42 6.56 ± 0.46 NS
Fibro Index 1.69 ± 0.18 0.73 ± 0.13 0.61 ± 0.25 <0.001
APRI 2.60 ± 0.40 0.79 ± 0.15 0.43 ± 0.11 <0.001
TE Transient Elastography, VTQ-L Virtual Touch™ quantification-Left lobe, VTQ-R Virtual Touch™ quantification-Right lobe, T-Bil total bilirubin, AST aspartate
aminotransferase, γ-GT gamma-glutamyl transpeptidase, ALP alkaline phosphatase, Plt platelet, T-cho total cholesterol, P-III-P procollagen-III-peptide, IV collagen,
type IV collagen 7S, APRI aspartate aminotransferase-to-platelet ratio index
All data are shown as means ± SE; *in comparison with Day 0 and Day 7

































































































Fig. 2 Changes in Serum Total Bilirubin (T-Bil) and Liver Elasticity. Liver elasticity was measured before and after biliary drainage. a Transient
Elastography (TE) and T-Bil values were elevated before drainage and significantly decreased at Day 7 after biliary drainage (left). Similarly, Virtual
touch quantification-Left lobe (VTQ-L) and Virtual touch quantification-Right lobe (VTQ-R) values were elevated before drainage and significantly
decreased at Day 7 after biliary drainage (right). b T-Bil, TE, VTQ-L, and VTQ-R values decreased rapidly from Day 0 to Day 2 in comparison with
from Day 2 to Day 7 after biliary drainage. VTQ-L value was significantly higher than VTQ-R value in each measurement date (right). c In 10
patients, who underwent further assessment after Day 7, TE, VTQ-L, and VTQ-R values further decreased. Data are shown as means ± SE;
** P < 0.01 versus Day0; ††P < 0.01 versus VTQ-R
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Only after-drainage decreases in HA, P-III-P, FibroIndex,
and APRI were significant. For the 10 patients evaluated
over the follow-up period, HA, P-III-P, IV collagen, Forns’
Index, Fibro Index, and APRI values further decreased,
respectively, to 118.0 ± 25.7 ng/ml, 0.09 ± 0.08 U/ml,
6.5 ± 0.8 ng/ml, 6.56 ± 0.46, 0.61 ± 0.25, and 0.43 ± 0.11
(Table 2 and Fig. 3a-f ).
Correlation between T-Bil, liver elasticity, and serum
markers of liver fibrosis
The correlation between T-Bil, TE, VTQ-L, and VTQ-R
values was tested. As shown in Fig. 4a-f, strong correla-
tions were apparent between VTQ-L and VTQ-R values
(r = 0.70, P < 0.001) and VTQ-L and TE values (r = 0.71,
P < 0.001). In addition, moderate correlations were ap-
parent between TE and T-Bil values (r = 0.51, P < 0.001),
VTQ-L and T-Bil values (r = 0.65, P < 0.001), VTQ-R
and T-Bil values (r = 0.41, P < 0.001), and VTQ-R and
TE values (r = 0.63, P < 0.001). The correlation between
liver elasticity and serum markers of liver fibrosis was
evaluated for markers which significantly decreased after
biliary drainage, namely P-III-P and HA. As shown in
Fig. 4g-l, moderate correlations were apparent between
TE and P-III-P values (r = 0.66, P < 0.001), VTQ-L and
P-III-P values (r = 0.63, P < 0.001), VTQ-R and P-III-P
values (r = 0.67, P < 0.001), TE and HA values (r = 0.47,
P < 0.001), and VTQ-R and HA values (r = 0.50, P < 0.001).
In addition, a weak correlation was apparent between
VTQ-L and HA values (r = 0.35, P < 0.001). The correla-
tions between serum markers and the Fibro Index and
APRI were not evaluated as decreases in these ratios were
considered to be influenced by the decrease in AST
(Table 2).
Correlation between alkaline phosphatase (ALP) and liver
elasticity
The correlations between ALP, TE, VTQ-L, and VTQ-R
were tested. Moderate correlation between VTQ-R and
ALP values (r = 0.46, P < 0.01) was seen. In addition,












































































Fig. 3 Changes in Serum Markers of Liver Fibrosis. a Hyaluronic acid (HA), b procollagen-III-peptide (P-III-P), c type IV collagen 7S (IV collagen),
d Forns’ Index, e Fibro Index, and (f) APRI were measured, before and after biliary drainage. HA, P-III-P, Fibro Index, and APRI were elevated
before drainage and decreased significantly at Day 7 after biliary drainage. IV collagen and Forns’ Index were elevated before drainage and
tended to decrease at Day 7 after biliary drainage. In 10 patients who underwent assessment after Day 7, all the markers decreased. Data are
shown as means ± SE; ** P < 0.01 versus Day 0
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also seen (r = 0.32, P < 0.01), while there was no correl-
ation between TE and ALP values (r = 0.073, P = 0.54).
Correlation among T-Bil, ALP, liver elasticity, and sites of
biliary obstruction
In hilar biliary obstruction (n = 7), the correlation be-
tween T-Bil, ALP, TE, VTQ-R, and VTQ-L were
tested. Moderate correlations were seen between TE
and T-Bil values (r = 0.48, P < 0.01), VTQ-L and T-Bil
values (r = 0.57, P < 0.01), while no correlation be-
tween VTQ-R and T-Bil values (r = 0.29, P = 0.13). In
addition, weak correlation between VTQ-R and ALP
values (r = 0.39, P < 0.04) was seen, while no correlations
between TE and ALP values (r = 0.21, P = 0.29), and
VTQ-L and ALP values (r = 0.19, P = 0.34) were seen.
Also in distal biliary obstruction (n = 13), the correl-
ation between T-Bil, ALP, TE, VTQ-R, and VTQ-L were
tested. Strong correlation was seen between VTQ-L and
T-Bil values (r = 0.71, P < 0.01). Moderate correlations were
seen between TE and T-Bil values (r = 0.45, P < 0.01),
VTQ-R and T-Bil values (r = 0.48, P < 0.01), and VTQ-R
and ALP values (r = 0.50, P < 0.01). Weak correlations were
seen between TE and ALP values (r = 0.30, P < 0.047),
VTQ-L and ALP values (r = 0.39, P < 0.01). In distal biliary
obstruction, correlations were seen between all of T-Bil,
ALP, TE, VTQ-R and VTQ-L.
Discussion
The main findings of our study are that liver elasticity,
measured by TE and VTQ, significantly decreased after
biliary drainage together with serum markers of liver fi-
brosis (P-III-P and HA), and that liver elasticity corre-
lated with levels of T-Bil, P-III-P, and HA. The rapid
decrease in liver elasticity from Day 0 to Day 2 indicates
that elevation in liver elasticity is influenced by elements
other than pathological liver fibrosis. The profile of ele-
vated liver elasticity before biliary drainage followed by a
rapid decrease after biliary drainage has previously been
reported in patients with obstructive jaundice [16–21].
The reported periods from biliary drainage to measure-
ment of liver elasticity varied among these studies: 2–11
days [16], 1–2 days and 3.0 ± 9.31 weeks [17], 27–32
days [19], 5–45 days [20], and 3–12 days [21]. Recently,



























































































































































(r=0.66, P ,36.0=r()100.0< P<0.001)
(r=0.67, P ,74.0=r()100.0< P<0.001)
(r=0.35, P ,05.0=r()110.0= P<0.001)
Fig. 4 Correlations between T-Bil, Liver Elasticity, and Serum Markers of Liver Fibrosis. a TE and T-Bil (r = 0.51, P < 0.001), b VTQ-L and T-Bil (r = 0.65,
P < 0.001), c VTQ-R and T-Bil (r = 0.41, P < 0.001), d VTQ-L and VTQ-R (r = 0.70, P < 0.001), e VTQ-L and TE (r = 0.71, P < 0.001), f VTQ-R and
TE (r = 0.63, P < 0.001), g TE and P-III-P (r = 0.66, P < 0.001), h VTQ-L and P-III-P (r = 0.63, P < 0.001), i VTQ-R and P-III-P (r = 0.67, P < 0.001),
j TE and HA (r = 0.47, P < 0.001), k VTQ-L and HA (r = 0.35, P < 0.001), l VTQ-R and HA (r = 0.50, P < 0.001)
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VTQ measures [16, 17]. However, one of these studies
included elasticity measured for liver conditions other
than obstructive jaundice, such as cholangitis [17], while
the other was limited by its small sample size (10 pa-
tients) and variation in lapse of time between drainage
and measurement of elasticity [16]. Our study excluded
patients with chronic liver disease, liver tumors, ascites,
and acute cholangitis, because these could also affect
liver elasticity. Additionally, we measured liver elasticity
within a very short lapse of time after biliary drainage
(i.e., Day 2 and Day 7) to avoid bias of longer or varying
observational period on measured values. More recently,
it has been reported that operator-related and patient-
related factors can produce significant variations in liver
elasticity measurements made by TE, which limits the
use of TE for longer-term monitoring of patients [24].
To avoid operator-related factors, liver elasticity was
measured by a single experienced operator in our study.
Accordingly, our results show more reliable measure-
ment than those reported in previous studies.
Changes in the Fibro Index after biliary drainage re-
flect changes in AST and γ-globulin levels, while
changes in APRI reflect changes in AST level. There-
fore, we did not consider the Fibro Index and the
APRI to directly reflect the stage of liver fibrosis. In
addition, it has been reported that HA is markedly
high in certain liver diseases, especially in patients
with cirrhosis, and that P-III-P is strongly correlated
with the histological degree of bridging in hepatocel-
lular necrosis and liver fibrosis in periportal areas [25,
26]. In our study, HA and P-III-P were elevated be-
fore biliary drainage, with levels significantly decreas-
ing after drainage. These changes in HA and P-III-P
partially reflect amelioration of liver fibrosis in ob-
structive jaundice after drainage. The mechanisms by
which high liver elasticity develops in obstructive
jaundice, however, is still unknown. One study dem-
onstrated that experimental blockage in bile flow re-
sulted in visible swelling of the liver, accompanied by
high liver elasticity [21].
VTQ is superior to TE in that VTQ can be used to
separately measure elasticity in both the left and right
lobes of the liver. A previous study reported VTQ to be
an accurate, reliable, reproducible, and non-invasive
method to assess liver fibrosis of both the left and right
lobes [27]. The consistently lower VTQ values for the
right, compared to the left, lobe of the liver reflects the
influences of movement of body organs, such as heart,
lungs, diaphragm, and stomach, against the left lobe of
the liver [27].
A weak and moderate correlation was apparent be-
tween ALP and VTQ-L, and ALP and VTQ-R in this
study, respectively. These results may be due to our
setting of chronic biliary obstruction.
The limitations of our study need to be considered.
This is a single center study, in which there is an inher-
ent bias in patient selection due to the referral patterns
to our institution. As well, measurements of liver elasti-
city were obtained by a non-blinded operator. The small
sample size of this study and the constraints on patient
selection may limit the ability to detect a higher correl-
ation between T-Bil, TE, VTQ-L, and VTQ-R. A multi-
center and larger cohort trial is needed to confirm our
results. Moreover, due to its invasiveness, liver biopsy
was not performed to rule out secondary liver fibrosis
due to bile duct obstruction after biliary drainage.
Additionally, in our study, correlation between liver
elasticity and hepatic functional reserve, such as indocy-
anine green test and 99mTc-GSA scintigraphy, was not
evaluated. These associations should be investigated in
future studies.
Conclusions
Our study clearly showed a decrease in liver elasticity,
evaluated by TE and VTQ, after biliary drainage.
Changes in liver elasticity were correlated to changes in
serum markers of liver fibrosis, P-III-P and HA
specifically.
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